Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
published in: PLOS One
date of publication: 2016-05-18
language: English
main subject: phase I clinical trial
Cites articles 28
Date
Title
Article - wd:Q36021144